Finland· FI-REL-REL39297
Sprimeo Hct
A aliskiren and hydrochlorothiazide product containing aliskiren hemifumarate + hydrochlorothiazide, registered in Finland by Novartis Europharm Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Aliskiren and hydrochlorothiazide is registered in 2 of 19 countries.
Countries holding a registration under ATC C09XA52 (aliskiren and hydrochlorothiazide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Aliskiren and hydrochlorothiazide · ATC C09XA52
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Aliskiren hemifumarate + Hydrochlorothiazide
- Manufacturer
- Novartis Europharm Ltd.
- Country
- Finland (FI)
- ATC code
- C09XA52
- ATC class
- Aliskiren and hydrochlorothiazide
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
51 interactions on record for aliskiren and hydrochlorothiazide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aliskiren and hydrochlorothiazide · interactions on record
51 records
51 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09XA52
Aliskiren and hydrochlorothiazide, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f17bdcc5-b725-4900-8009-9751085dd976 GET /v1/drugs/f17bdcc5-b725-4900-8009-9751085dd976?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": null,
"strength": "150 mg / 25 mg",
"atc_label": "aliskireeni ja hydroklooritiatsidi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/11/683/021-040",
"fimea_rel_id": "REL39297",
"authorised_at": "2011-06-23"
}See everything about aliskiren and hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.